Evidence map›Paper›PMID 36945530›Full record

ArticlebioRxiv : the preprint server for biology2024

A multiscale functional map of somatic mutations in cancer integrating protein structure and network topology.

Yingying Zhang, Alden K Leung, Jin Joo Kang, Yu Sun, Guanxi Wu, Le Li, Jiayang Sun, Lily Cheng, Tian Qiu, Junke Zhang and 4 more

Open access · greenFull text readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Yingying ZhangDepartment of Computational Biology, Cornell University; Ithaca, 14853, USA.ORCID 0000-0003-3819-5467
Alden K LeungDepartment of Computational Biology, Cornell University; Ithaca, 14853, USA.
Jin Joo KangDepartment of Computational Biology, Cornell University; Ithaca, 14853, USA.
Yu SunDepartment of Computational Biology, Cornell University; Ithaca, 14853, USA.
Guanxi WuCollege of Agriculture and Life Sciences, Cornell University; Ithaca, 14853, USA.
Le LiDepartment of Computational Biology, Cornell University; Ithaca, 14853, USA.
Jiayang SunDepartment of Computational Biology, Cornell University; Ithaca, 14853, USA.
Lily ChengDepartment of Science and Technology Studies, Cornell University; Ithaca, 14853, USA.
Tian QiuSchool of Electrical and Computer Engineering, Cornell University; Ithaca, 14853, USA.
Junke ZhangDepartment of Computational Biology, Cornell University; Ithaca, 14853, USA.
Shayne WierbowskiDepartment of Computational Biology, Cornell University; Ithaca, 14853, USA.ORCID 0000-0002-2595-2011
Shagun GuptaDepartment of Computational Biology, Cornell University; Ithaca, 14853, USA.
James BoothDepartment of Computational Biology, Cornell University; Ithaca, 14853, USA.
Haiyuan YuDepartment of Computational Biology, Cornell University; Ithaca, 14853, USA.ORCID 0000-0001-7597-6049
Cornell University · US

Funding

Integrated high-throughput functional assays to identify ulcerative colitis causal risk variantsR01DK115398 · NIDDK · CORNELL UNIVERSITY · PI KLEIN, ROBERT J., YU, HAIYUAN · 2018 to 2022
$3.3M
Quantifying molecular consequences of human missense variants with large-scale interactome perturbation studiesR01GM125639 · NIGMS · CORNELL UNIVERSITY · PI ALEXOV, EMIL GEORGIEV, CLARK, ANDREW G · 2018 to 2021
$2.6M
Towards a comprehensive multiscale 3D human interactome networkR01GM124559 · NIGMS · CORNELL UNIVERSITY · PI YU, HAIYUAN · 2017 to 2020
$1.5M
NIDDK NIH HHS R01 DK115398NIGMS NIH HHS R01 GM124559NIGMS NIH HHS R01 GM125639
6 · The paper itself

Abstract

A major goal of cancer biology is to understand the mechanisms underlying tumorigenesis driven by somatically acquired mutations. Two distinct types of computational methodologies have emerged: one focuses on analyzing clustering of mutations within protein sequences and 3D structures, while the other characterizes mutations by leveraging the topology of protein-protein interaction network. Their insights are largely non-overlapping, offering complementary strengths. Here, we established a unified, end-to-end 3D structurally-informed protein interaction network propagation framework, NetFlow3D, that systematically maps the multiscale mechanistic effects of somatic mutations in cancer. The establishment of NetFlow3D hinges upon the Human Protein Structurome, a comprehensive repository we compiled that incorporates the 3D structures of every single protein as well as the binding interfaces of all known protein interactions in humans. NetFlow3D leverages the Structurome to integrate information across atomic, residue, protein and network levels: It conducts 3D clustering of mutations across atomic and residue levels on protein structures to identify potential driver mutations. It then anisotropically propagates their impacts across the protein interaction network, with propagation guided by the specific 3D structural interfaces involved, to identify significantly interconnected network "modules", thereby uncovering key biological processes underlying disease etiology. Applied to 1,038,899 somatic protein-altering mutations in 9,946 TCGA tumors across 33 cancer types, NetFlow3D identified 1,4444 significant 3D clusters throughout the Human Protein Structurome, of which ~55% would not have been found if using only experimentally-determined structures. It then identified 26 significantly interconnected modules that encompass ~8-fold more proteins than applying standard network analyses. NetFlow3D and our pan-cancer results can be accessed from http://netflow3d.yulab.org.

Identifiers

PMID36945530
PMCPMC10028849
OpenAlexW4323349878

What OpenQuestion holds

Textfull text, public
LicenceCC BY
measurements read89
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.